TotalMarketCap

Praxis Precision Medicines

PRAXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$7.343 B

$263.01 -7.65%

Close of 6 Nov 2026

As of 6 Nov 2026, Praxis Precision Medicines (PRAX) has a market capitalization of $7.34B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$303.0M

Loss-making

Shares outstanding

27,919,988

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #40AlkermesALKS$7.50B
  2. #41AbivaxABVX$7.35B
  3. #42Praxis Precision MedicinesPRAX$7.34B
  4. #43Rhythm PharmaceuticalsRYTM$7.21B
  5. #44Kiniksa Pharmaceuticals InternationalKNSA$6.95B

What if Praxis Precision Medicines were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,011,350

Per share 3,845× higher

Bitcoin $1.53T

$54,722.38

Per share 208× higher

Apple $5.02T

$179,648.45

Per share 683× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Praxis Precision Medicines are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.